Updates on Sjögren’s syndrome: from proteomics to protein biomarkers

References

• Ferro F, Vagelli R, Bruni C, et al. One year in review 2016: sjogren’s syndrome. Clin Exp Rheumatol. 2016;34:161–171.
   PubMed Web of Science ®Google Scholar
• Barone F, Colafrancesco S. Sjogren’s syndrome: from pathogenesis to novel therapeutic targets. Clin Exp Rheumatol. 2016;34:58–62.
   PubMed Web of Science ®Google Scholar
• Baldini C, Pepe P, Quartuccio L, et al. Primary Sjogren’s syndrome as a multi-organ disease: impact of the serological profile on the clinical presentation of the disease in a large cohort of Italian patients. Rheumatology. 2014;53:839–844.
   PubMed Web of Science ®Google Scholar
• Brito-Zeron P, Baldini C, Bootsma H, et al. Sjogren syndrome. Nat Rev Dis Primers. 2016;2:16047.
   PubMed Web of Science ®Google Scholar
• Luciano N, Valentini V, Calabro A, et al. One year in review 2015: sjogren’s syndrome. Clin Exp Rheumatol. 2015;33:259–271.
   PubMed Web of Science ®Google Scholar
• Epstein JB, Villines DC, Sroussi HY. Oral symptoms and oral function in people with Sjogren’s syndrome. Clin Exp Rheumatol. 2015;33:132–133.
   PubMed Web of Science ®Google Scholar
• Voulgarelis M, Tzioufas AG. Current aspects of pathogenesis in Sjogren’s syndrome. Ther Adv Musculoskelet Dis. 2010;2:325–334.
   PubMedGoogle Scholar
• Capaldo C, Carvajal Alegria G, Cornec D, et al. The active immunological profile in patients with primary Sjogren’s syndrome is restricted to typically encountered autoantibodies. Clin Exp Rheumatol. 2016;34:722.
   PubMed Web of Science ®Google Scholar
• Goules AV, Tzioufas AG. Primary Sjogren’s syndrome: clinical phenotypes, outcome and the development of biomarkers. Immunol Res. 2017 Feb;65(1):331-334.
   PubMed Web of Science ®Google Scholar
• Baldini C, Giusti L, Bazzichi L, et al. Proteomic analysis of the saliva: a clue for understanding primary from secondary Sjogren’s syndrome? Autoimmun Rev. 2008;7:185–191.
   PubMed Web of Science ®Google Scholar
• Gallo A, Baldini C, Teos L, et al. Emerging trends in Sjogren’s syndrome: basic and translational research. Clin Exp Rheumatol. 2012;30:779–784.
   PubMed Web of Science ®Google Scholar
• Erickson BE. Tears hold clues to eye disease. J Proteome Res. 2005;4:664.
   PubMedGoogle Scholar
• Von Thun Und Hohenstein-Blaul N, Funke S, Grus FH. Tears as a source of biomarkers for ocular and systemic diseases. Exp Eye Res. 2013;117:126–137.
   PubMed Web of Science ®Google Scholar
• Aqrawi LA, Galtung HK, Vestad B, et al. Identification of potential saliva and tear biomarkers in primary Sjogren’s syndrome, utilising the extraction of extracellular vesicles and proteomics analysis. Arthritis Res Ther. 2017;19:14.
   PubMed Web of Science ®Google Scholar
• Li B, Sheng M, Li J, et al. Tear proteomic analysis of Sjogren syndrome patients with dry eye syndrome by two-dimensional-nano-liquid chromatography coupled with tandem mass spectrometry. Sci Rep. 2014;4:5772.
   PubMed Web of Science ®Google Scholar
• Zhou L, Wei R, Zhao P, et al. Proteomic analysis revealed the altered tear protein profile in a rabbit model of Sjogren’s syndrome-associated dry eye. Proteomics. 2013;13:2469–2481.
   PubMed Web of Science ®Google Scholar
• Baldini C, Gallo A, Perez P, et al. Saliva as an ideal milieu for emerging diagnostic approaches in primary Sjogren’s syndrome. Clin Exp Rheumatol. 2012;30:785–790.
   PubMed Web of Science ®Google Scholar
• Tzioufas AG, Kapsogeorgou EK. Biomarkers. Saliva proteomics is a promising tool to study Sjogren syndrome. Nat Rev Rheumatol. 2015;11:202–203.
   PubMed Web of Science ®Google Scholar
• Ruhl S. The scientific exploration of saliva in the post-proteomic era: from database back to basic function. Expert Rev Proteomics. 2012;9:85–96.
   PubMed Web of Science ®Google Scholar
• Huang CM. Comparative proteomic analysis of human whole saliva. Arch Oral Biol. 2004;49:951–962.
   PubMed Web of Science ®Google Scholar
• Vissink A, Panders AK, Nauta JM, et al. Applicability of saliva as a diagnostic fluid in Sjogren’s syndrome. Ann N Y Acad Sci. 1993;694:325–329.
   PubMed Web of Science ®Google Scholar
• Deutsch O, Fleissig Y, Zaks B, et al. An approach to remove alpha amylase for proteomic analysis of low abundance biomarkers in human saliva. Electrophoresis. 2008;29:4150–4157.
   PubMed Web of Science ®Google Scholar
• Giusti L, Baldini C, Bazzichi L, et al. Proteomic diagnosis of Sjogren’s syndrome. Expert Rev Proteomics. 2007;4:757–767.
   PubMed Web of Science ®Google Scholar
• Vissink A, Spijkervet FK, van Nieuw Amerongen A. Aging and saliva: a review of the literature. Spec Care Dentist. 1996;16:95–103.
   PubMedGoogle Scholar
• Vissink A, Veerman EC, van Nieuw Amerongen A. [Saliva diagnosis: the future becomes the present reality]. Ned Tijdschr Tandheelkd. 2007;114:468–473.
   PubMedGoogle Scholar
• Baldini C, Giusti L, Ciregia F, et al. Proteomic analysis of saliva: a unique tool to distinguish primary Sjogren’s syndrome from secondary Sjogren’s syndrome and other sicca syndromes. Arthritis Res Ther. 2011;13:R194.
   PubMed Web of Science ®Google Scholar
• Hu S, Wang J, Meijer J, et al. Salivary proteomic and genomic biomarkers for primary Sjogren’s syndrome. Arthritis Rheum. 2007;56:3588–3600.
   PubMed Web of Science ®Google Scholar
• Hu S, Gao K, Pollard R, et al. Preclinical validation of salivary biomarkers for primary Sjogren’s syndrome. Arthritis Care Res (Hoboken). 2010;62:1633–1638.
   PubMed Web of Science ®Google Scholar
• Ambatipudi KS, Swatkoski S, Moresco JJ, et al. Quantitative proteomics of parotid saliva in primary Sjogren’s syndrome. Proteomics. 2012;12:3113–3120.
   PubMed Web of Science ®Google Scholar
• Delaleu N, Mydel P, Brun JG, et al. Sjogren’s syndrome patients with ectopic germinal centers present with a distinct salivary proteome. Rheumatology. 2016;55:1127–1137.
   PubMed Web of Science ®Google Scholar
• Delaleu N, Mydel P, Kwee I, et al. High fidelity between saliva proteomics and the biologic state of salivary glands defines biomarker signatures for primary Sjogren’s syndrome. Arthritis & Rheumatology. 2015;67:1084–1095.
   PubMed Web of Science ®Google Scholar
• Deutsch O, Krief G, Konttinen YT, et al. Identification of Sjogren’s syndrome oral fluid biomarker candidates following high-abundance protein depletion. Rheumatology. 2015;54:884–890.
   PubMed Web of Science ®Google Scholar
• Heijnen HF, Schiel AE, Fijnheer R, et al. Activated platelets release two types of membrane vesicles: microvesicles by surface shedding and exosomes derived from exocytosis of multivesicular bodies and alpha-granules. Blood. 1999;94:3791–3799.
   PubMed Web of Science ®Google Scholar
• McLellan AD. Exosome release by primary B cells. Crit Rev Immunol. 2009;29:203–217.
   PubMed Web of Science ®Google Scholar
• Admyre C, Telemo E, Almqvist N, et al. Exosomes - nanovesicles with possible roles in allergic inflammation. Allergy. 2008;63:404–408.
   PubMed Web of Science ®Google Scholar
• Gallo A, Tandon M, Alevizos I, et al. The majority of microRNAs detectable in serum and saliva is concentrated in exosomes. Plos One. 2012;7:e30679.
   PubMed Web of Science ®Google Scholar
• Ogawa Y, Miura Y, Harazono A, et al. Proteomic analysis of two types of exosomes in human whole saliva. Biol Pharm Bull. 2011;34:13–23.
   PubMed Web of Science ®Google Scholar
• Thery C, Amigorena S, Raposo G, et al. Isolation and characterization of exosomes from cell culture supernatants and biological fluids. Curr Protoc Cell Biol. 2006 Apr;Chapter 3:Unit 3.22. doi: 10.1002/0471143030.cb0322s30.
   PubMedGoogle Scholar
• Gallo A, Alevizos I. Isolation of circulating microRNA in saliva. Methods Mol Biol. 2013;1024:183–190.
   PubMedGoogle Scholar
• Raposo G, Nijman HW, Stoorvogel W, et al. B lymphocytes secrete antigen-presenting vesicles. J Exp Med. 1996;183:1161–1172.
   PubMed Web of Science ®Google Scholar
• Kapsogeorgou EK, Abu-Helu RF, Moutsopoulos HM, et al. Salivary gland epithelial cell exosomes: A source of autoantigenic ribonucleoproteins. Arthritis Rheum. 2005;52:1517–1521.
   PubMed Web of Science ®Google Scholar
• Alevizos I, Alexander S, Turner RJ, et al. MicroRNA expression profiles as biomarkers of minor salivary gland inflammation and dysfunction in Sjogren’s syndrome. Arthritis Rheum. 2011;63:535–544.
   PubMed Web of Science ®Google Scholar
• Ryu OH, Atkinson JC, Hoehn GT, et al. Identification of parotid salivary biomarkers in Sjogren’s syndrome by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry and two-dimensional difference gel electrophoresis. Rheumatology. 2006;45:1077–1086.
   PubMed Web of Science ®Google Scholar
• Giusti L, Baldini C, Bazzichi L, et al. Proteome analysis of whole saliva: a new tool for rheumatic diseases–the example of Sjogren’s syndrome. Proteomics. 2007;7:1634–1643.
   PubMed Web of Science ®Google Scholar
• Peluso G, De Santis M, Inzitari R, et al. Proteomic study of salivary peptides and proteins in patients with Sjogren’s syndrome before and after pilocarpine treatment. Arthritis Rheum. 2007;56:2216–2222.
   PubMed Web of Science ®Google Scholar
• Fleissig Y, Deutsch O, Reichenberg E, et al. Different proteomic protein patterns in saliva of Sjogren’s syndrome patients. Oral Dis. 2009;15:61–68.
   PubMed Web of Science ®Google Scholar
• Deutsch O, Krief G, Konttinen YT, et al. Identification of Sjogren’s syndrome oral fluid biomarker candidates following high-abundance protein depletion. Rheumatology (Oxford). 2015 May;54(5):884-890.
   Web of Science ®Google Scholar
• Giusti L, Baldini C, Ciregia F, et al. Is GRP78/BiP a potential salivary biomarker in patients with rheumatoid arthritis? Proteomics Clin Applications. 2010;4:315–324.
   PubMed Web of Science ®Google Scholar
• Giusti L, Bazzichi L, Baldini C, et al. Specific proteins identified in whole saliva from patients with diffuse systemic sclerosis. J Rheumatol. 2007;34:2063–2069.
   PubMed Web of Science ®Google Scholar
• Kandalaft PL, Simon RA, Isacson C, et al. Comparative sensitivities and specificities of antibodies to breast markers GCDFP-15, mammaglobin A, and different clones of antibodies to GATA-3: a study of 338 tumors using whole sections. Appl Immunohistochem Mol Morphol. 2016;24:609–614.
   PubMedGoogle Scholar
• Yoshimura S, Nakamura H, Horai Y, et al. Abnormal distribution of AQP5 in labial salivary glands is associated with poor saliva secretion in patients with Sjogren’s syndrome including neuromyelitis optica complicated patients. Mod Rheumatology. 2016;26:384–390.
   PubMed Web of Science ®Google Scholar
• Gallo A, Martini D, Sernissi F, et al. Gross cystic disease fluid protein-15(GCDFP-15)/prolactin-inducible protein (PIP) as functional salivary biomarker for primary Sjogren’s syndrome. J Genet Syndr Gene Ther. 2013 Jun 15;4. doi: 10.4172/2157-7412.1000140.
   Google Scholar
• Nicaise C, Weichselbaum L, Schandene L, et al. Phagocyte-specific S100A8/A9 is upregulated in primary Sjogren’s syndrome and triggers the secretion of pro-inflammatory cytokines in vitro. Clin Exp Rheumatol. 2017 Jan-Feb;35(1):129-136.
   Web of Science ®Google Scholar
• Bierkarre H, Harder J, Cuthbert R, et al. Differential expression of antimicrobial peptides in psoriasis and psoriatic arthritis as a novel contributory mechanism for skin and joint disease heterogeneity. Scand J Rheumatol. 2016;45:188–196.
   PubMed Web of Science ®Google Scholar
• Baldini C, Giusti L, Bazzichi L, et al. Association of psoriasin (S100A7) with clinical manifestations of systemic sclerosis: is its presence in whole saliva a potential predictor of pulmonary involvement? J Rheumatol. 2008;35:1820–1824.
   PubMed Web of Science ®Google Scholar
• Gottenberg JE, Seror R, Miceli-Richard C, et al. Serum levels of beta2-microglobulin and free light chains of immunoglobulins are associated with systemic disease activity in primary Sjogren’s syndrome data at enrollment in the prospective ASSESS cohort. Plos One. 2013;8:e59868.
   PubMed Web of Science ®Google Scholar
• Martini D, Gallo A, Vella S, et al. Cystatin S-a candidate biomarker for severity of submandibular gland involvement in Sjogren’s syndrome. Rheumatology. 2017.
   PubMedGoogle Scholar
• Baldini C, Giusti L, Ciregia F, et al. Correspondence between salivary proteomic pattern and clinical course in primary Sjogren syndrome and non-Hodgkin’s lymphoma: a case report. J Transl Med. 2011;9:188.
   PubMed Web of Science ®Google Scholar